Loading...

Purified anti-mouse CD3ε Antibody

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
145-2C11_Pure_021606
C57BL/6 mouse splenocytes were stained with purified CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by anti-Armenian hamster IgG FITC.
  • 145-2C11_Pure_021606
    C57BL/6 mouse splenocytes were stained with purified CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by anti-Armenian hamster IgG FITC.
  • 145-2C11_PURE_CD3e_Antibody_IHC-F_033017
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for ten minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then the section was stained with 10 µg/mL of purified anti-mouse CD3ε (clone 145-2C11) and 10 µg/mL of Alexa Fluor® 488 anti-mouse/human CD45R/B220 (clone RA3-6B2) (green) overnight at 4°C, followed by 2.5 µg/mL of Alexa Fluor® 594 Goat anti-hamster (Armenian) IgG (clone Poly4055) (red) for two hours at room temperature. The image was captured by 10X objective.
  • 145-2C11_PURE_CD3e_Antibody_IHC-F_2_102518
    Fresh, frozen mouse spleen was stained with purified CD3ε clone 145-2C11 conjugated and detected with a Cy3 CODEX™ oligonucleotide duplex (red). Samples were counterstained with B220 A647 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
100301 50 µg $24
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100302 500 µg $72
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The CD3ε antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F - Verified
IP, Activ, Block, WB, ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cells in 100 µl volume. For immunohistochemical staining on frozen tissue sections, the suggested use of this reagent is 5.0 - 10 µg per ml. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed
  2. Akiyama C, et al. 2019. J Immunol. 203:835. PubMed
  3. Bergfeld A, et al. 2017. Front Microbiol. 0.919444444. PubMed
  4. Chemnitz J, et al. 2019. Sci Rep. 3.745138889. PubMed
  5. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  6. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  7. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  8. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  9. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  10. Tian J, et al. 2021. Autophagy. 17:2586. PubMed
  11. Tersteegen A, et al. 2021. Infect Immun. 89:. PubMed
  12. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  13. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  14. Biljes D, et al. 2017. EXCLI J. 0.86875. PubMed
  15. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  16. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  17. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  18. Namavari A, et al. 2012. Invest Ophthalmol Vis Sci . 53:4575. PubMed
  19. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  20. Goel S, et al. 2017. Nature. 548:471. PubMed
  21. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  22. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  23. McLane LM, et al. 2021. Cell Reports. 35(6):109120. PubMed
  24. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  25. Sanctuary MR, et al. 2019. Mucosal Immunol. 0.638888889. PubMed
  26. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  27. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  28. Crawford G, et al. 2018. Nat Immunol. 1.388194444. PubMed
  29. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  30. Oghumu S, et al. 2019. J Immunol. 203:789. PubMed
  31. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  32. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  33. Jennings EK, et al. 2021. STAR Protocols. 2(1):100284. PubMed
  34. Lu SX, et al. 2021. Cell. . PubMed
  35. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  36. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  37. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  38. Liu W, et al. 2021. Stem Cell Res Ther. 12:153. PubMed
  39. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  40. Willimsky G, et al. 2021. Elife. 10:. PubMed
  41. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  42. Muhammad F, et al. 2020. Front Immunol. 975:11. PubMed
  43. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  44. Edenborough KM, et al. 2019. Front Immunol. 10:2414. PubMed
  45. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  46. Robert S, et al. 2018. Bone Marrow Transplant. 53:807. PubMed
  47. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  48. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  49. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  50. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  51. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  52. Sekiya T et al. 2018. Cell reports. 24(6):1627-1638 . PubMed
  53. Lyon de Ana C, et al. 2019. J Immunol. 202:1112. PubMed
  54. Wu P et al. 2019. Molecular cell. 73(5):1015-1027 . PubMed
  55. Tuzlak S, et al. 2017. Cell Death Differ. 24:523. PubMed
  56. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  57. Rao TN, et al. 2020. J Immunol. 204:2600. PubMed
  58. Perchonock C, et al. 2006. Mol Cell Biol . 26:6005. PubMed
  59. Guo Y, et al. 2008. Blood. 112:480. PubMed
  60. El Maï M, et al. 2021. Cancers (Basel). 13:. PubMed
  61. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  62. Mullins GN, et al. 2020. Sci Rep. 10:21994. PubMed
  63. Hilligan KL, et al. 2020. Nat Commun. 11:5637. PubMed
  64. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  65. Hanoteau A, et al. 2019. J Immunother Cancer. 7:10. PubMed
  66. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  67. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  68. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  69. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  70. McCully M, et al. 2015. J Immunol. 195: 96 - 104. PubMed
  71. Bremser A, et al. 2015. PLoS One. 10: 0137393. PubMed
  72. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  73. Takushi SE, et al. 2020. Hum Gene Ther. 31:626. PubMed
  74. Chen Z et al. 2019. Immunity. 51(5):840-855 . PubMed
  75. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  76. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  77. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  78. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  79. Reed J, et al. 2020. Bio Protoc. 10:e3607. PubMed
  80. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  81. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  82. Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
  83. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  84. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  85. Hsieh WC, et al. 2020. JCI Insight. 5:00. PubMed
  86. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  87. Won HY, et al. 2017. Sci Rep. 7:16946. PubMed
  88. Van De Velde LA, et al. 2017. J Biol Chem. 292:15:00. PubMed
  89. Scholz T, et al. 2017. PLoS One. 12:e0182646. PubMed
  90. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  91. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  92. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  93. Du J, et al. 2018. AMB Express. 8:158. PubMed
  94. Majer O, et al. 2019. Nature. 575:366. PubMed
  95. Sun L, et al. 2022. Front Immunol. 13:823853. PubMed
  96. Wu G, et al. 2022. Wellcome Open Res. 6:134. PubMed
  97. Otsuka S, et al. 2021. J Clin Invest. 131:. PubMed
  98. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  99. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  100. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  101. Seo N, et al. 2018. Nat Commun. 9:435. PubMed
  102. Parzmair GP, et al. 2017. J Leukoc Biol. 101:407. PubMed
  103. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  104. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  105. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  106. Hao Y, et al. 2018. Front Immunol. 9:1127. PubMed
  107. Ma VP, et al. 2022. Sci Adv. 8:eabg4485. PubMed
  108. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  109. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  110. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  111. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  112. Sandy A, et al. 2013. J Immunol. 190:5818. PubMed
  113. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  114. Katagiri T, et al. 2019. Mucosal Immunol. 12:p1104. PubMed
  115. Wang HC, et al. 2017. J Immunol. 198:3149. PubMed
  116. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  117. Klein JC, et al. 2017. Nat Commun. 8:14600. PubMed
  118. Sripada A, et al. 2021. PLoS Biol. 19:e3001063. PubMed
  119. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  120. Wu Y, et al. 2021. J Clin Invest. 131:. PubMed
  121. Rigo MM, et al. 2020. FEBS J. :. PubMed
  122. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  123. Spranger S, et al. 2017. Cancer Cell. 31:711. PubMed
  124. Wang W, et al. 2018. J Vasc Surg. 68:1538. PubMed
  125. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  126. Lee J, et al. 2020. Cells. 9:. PubMed
  127. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  128. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  129. Link MA, et al. 2017. PLoS One. 12:e0184320. PubMed
  130. Teijeira A, et al. 2018. Cancer Immunol Res. 6:798. PubMed
  131. Jiao S, et al. 2020. Cell. 179(5):1177-1190.e13.. PubMed
  132. Aguilar OA, et al. 2020. J Immunol. 205:1709. PubMed
  133. Taylor MD, et al. 2020. Front Immunol. 11:1946. PubMed
  134. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  135. Yoon S, et al. 2022. Nat Commun. 13:1602. PubMed
  136. Chen Z, et al. 2021. Cell. 184(5):1262-1280.e22. PubMed
  137. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  138. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  139. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  140. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  141. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  142. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  143. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  144. Koch K, et al. 2022. Int J Mol Sci. 23:. PubMed
  145. Yang H, et al. 2022. Cell Death Discov. 8:183. PubMed
  146. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  147. Sun Y, et al. 2021. Nat Commun. 12:5147. PubMed
  148. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  149. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  150. Afzali B, et al. 2017. Nat Immunol. 18:813. PubMed
  151. Cohen MA, et al. 2020. Cell Stem Cell. 26(4):579-592. PubMed
  152. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  153. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  154. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  155. Perchonock C, et al. 2007. J Immunol. 179:1768. PubMed
  156. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  157. Abe Y, et al. 2017. Biochem Biophys Rep. 0.543055556. PubMed
  158. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  159. Lin J, et al. 2017. Nat Commun. . 10.1038/s41467-017-01477-5. PubMed
  160. Taylor MD, et al. 2020. Front Immunol. 11:563402. PubMed
  161. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  162. Sasai M, et al. 2021. J Exp Med. 218:. PubMed
  163. Wang G, et al. 2015. PLoS One. 10:121968. PubMed
  164. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  165. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  166. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  167. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  168. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  169. Akkaya B, et al. 2018. J Immunol. 201:3294. PubMed
  170. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  171. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  172. Bordoloi D, et al. 2021. Genes Cancer. 12:51. PubMed
  173. Wang W, et al. 2022. Nat Commun. 13:4495. PubMed
  174. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  175. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  176. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  177. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  178. Yamazaki K, et al. 2022. Sci Rep. 12:3242. PubMed
  179. Chen YH, et al. 2022. Arthritis Res Ther. 24:27. PubMed
  180. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
  181. Xia L, et al. 2021. Cancer Immunol Res. 9:707. PubMed
RRID
AB_312666 (BioLegend Cat. No. 100301)
AB_312667 (BioLegend Cat. No. 100302)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 10/17/2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account